Literature DB >> 10091966

Substance dependence and personality disorders: comorbidity and treatment outcome in an inpatient treatment population.

V H Thomas1, T P Melchert, J A Banken.   

Abstract

OBJECTIVE: Personality disorders (PDs) are common among patients with substance dependence, and antisocial PD in particular has been found to have a significant impact on treatment outcomes. Relatively little is known about other comorbid PDs, however. This study was designed to clarify the distribution of PDs among substance dependent patients and assess their role in treatment outcome.
METHOD: PDs and substance use disorders were diagnosed for 252 (181 male) consecutively admitted substance dependent inpatients using structured clinical interviews. A subsample of these (n = 104) were also followed for 1 year to monitor treatment outcome and relapse.
RESULTS: Fifty percent of the patients were diagnosed with one or more personality disorders, but no consistent relationships between drug of choice and PDs were found. The likelihood of relapse, however, increased significantly with the diagnosis of a PD. Only 6% of the patients who received more than one PD diagnosis were maintaining sobriety at the end of 1 year compared with 44% of those with no PD diagnoses. A preference for cocaine was also a significant predictor of relapse.
CONCLUSIONS: The low participation rate for the treatment outcome study and other methodological limitations render the study results tentative. Nevertheless, the findings suggest that more attention should be given to Axis II disorders in substance dependence research and treatment.

Entities:  

Mesh:

Year:  1999        PMID: 10091966     DOI: 10.15288/jsa.1999.60.271

Source DB:  PubMed          Journal:  J Stud Alcohol        ISSN: 0096-882X


  10 in total

1.  Relapse Contexts for Substance Abusing Adolescents with Comorbid Psychopathology.

Authors:  Kristen G Anderson; Kevin C Frissell; Sandra A Brown
Journal:  J Child Adolesc Subst Abuse       Date:  2007

2.  The relation between antisocial and borderline personality symptoms and early maladaptive schemas in a treatment seeking sample of male substance users.

Authors:  Ryan C Shorey; Scott Anderson; Gregory L Stuart
Journal:  Clin Psychol Psychother       Date:  2013-05-06

Review 3.  Substance use disorder and personality disorder.

Authors:  Kenneth J Sher; Timothy J Trull
Journal:  Curr Psychiatry Rep       Date:  2002-02       Impact factor: 5.285

4.  The impact of borderline personality disorder on residential substance abuse treatment dropout among men.

Authors:  Matthew T Tull; Kim L Gratz
Journal:  Drug Alcohol Depend       Date:  2011-09-09       Impact factor: 4.492

5.  Personality disorders and retention in a therapeutic community for substance dependence.

Authors:  Douglas B Samuel; Donna M LaPaglia; Lisa M Maccarelli; Brent A Moore; Samuel A Ball
Journal:  Am J Addict       Date:  2011-10-04

Review 6.  [Application of dialectical behavior therapy as in-patient treatment for alcohol dependency].

Authors:  F Mayer-Bruns; K Lieb; E Dannegger; G A Jacob
Journal:  Nervenarzt       Date:  2005-03       Impact factor: 1.214

7.  Personality Pathology and Substance Misuse in Later Life: Perspectives from Interviewer-, Self-, and Informant-Reports.

Authors:  Sarah E Paul; Rachel P Winograd; Thomas F Oltmanns
Journal:  J Psychopathol Behav Assess       Date:  2021-01-02

8.  Choice, deliberation, violence: Mental capacity and criminal responsibility in personality disorder.

Authors:  Hanna Pickard
Journal:  Int J Law Psychiatry       Date:  2015-05-18

9.  Relationship between the Level of Motivation and Personality Disorder in Patients with Opioid Dependence Syndrome.

Authors:  Manu Sharma; Sankalp Doda; Devendra Mohan Mathur; Jitendra Jeenger
Journal:  Indian J Psychol Med       Date:  2020-03-09

10.  Anxiety and Depression in Drug-Dependent Patients with Cluster C Personality Disorders.

Authors:  Carlos Roncero; Adelia de Miguel; Ascensión Fumero; Alfonso C Abad; Rita Martín; Juan Manuel Bethencourt; Lara Grau-López; Laia Rodríguez-Cintas; Constanza Daigre
Journal:  Front Psychiatry       Date:  2018-02-08       Impact factor: 4.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.